Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2026-03-03 @ 5:04 PM
Study NCT ID:
NCT03790592
Status:
COMPLETED
Last Update Posted:
2020-07-16
First Post:
2018-12-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Visual Outcomes After Presbyopic Lens Exchange
Sponsor:
Carl Zeiss Meditec AG
Organization:
Study Overview
Official Title:
Visual Outcomes and Patient Satisfaction After Presbyopic Lens Exchange With a Trifocal Intraocular Lens (IOL)
Status:
COMPLETED
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RELAX
Brief Summary:
Evaluation of mean preoperative and postoperative Corrected distance visual acuity (CDVA) after Refractive Lens Exchange in presbyopic patients
Detailed Description:
Compare preoperative and postoperative Corrected distance visual acuity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: